title: Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose.
abstract: OBJECTIVE
  Endothelial dysfunction is a feature of hypertension and diabetes. Methylglyoxal (MG) is a reactive dicarbonyl metabolite of glucose and its levels are elevated in spontaneously hypertensive rats and in diabetic patients. We investigated if MG induces endothelial dysfunction and whether MG scavengers can prevent endothelial dysfunction induced by MG and high glucose concentrations.
  
  
  METHODS
  Endothelium-dependent relaxation was studied in aortic rings from Sprague-Dawley rats. We also used cultured rat aortic and human umbilical vein endothelial cells. The MG was measured by HPLC and Western blotting and assay kits were used.
  
  
  RESULTS
  Incubation of aortic rings with MG (30 µM) or high glucose (25 mM) attenuated endothelium-dependent, acetylcholine-induced relaxation, which was restored by two different MG scavengers, aminoguanidine (100 µM) and N-acetyl cysteine (NAC) (600 µM). Treatment of cultured endothelial cells with MG or high glucose increased cellular MG levels, effects prevented by aminoguanidine and NAC. In cultured endothelial cells, MG and high glucose reduced basal and bradykinin-stimulated nitric oxide (NO) production, cGMP levels, and serine-1177 phosphorylation and activity of endothelial NO synthase (eNOS), without affecting threonine-495 and Akt phosphorylation or total eNOS protein. These effects of MG and high glucose were attenuated by aminoguanidine or NAC.
  
  
  CONCLUSIONS
  Our results show for the first time that MG reduced serine-1177 phosphorylation, activity of eNOS and NO production. MG caused endothelial dysfunction similar to that induced by high glucose. Specific and safe MG scavengers have potential to prevent endothelial dysfunction induced by MG and high glucose concentrations.
authors.affiliation: Department of Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: Arti
authors.initials: A
authors.lastname: Dhar
authors.forename: Indu
authors.initials: I
authors.lastname: Dhar
authors.forename: Kaushik M
authors.initials: KM
authors.lastname: Desai
authors.forename: Lingyun
authors.initials: L
authors.lastname: Wu
mesh_terms: D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000111:Acetylcysteine / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000378:metabolism; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D005947:Glucose / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D006146:Guanidines / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011765:Pyruvaldehyde / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D014652:Vascular Diseases / Q000378:metabolism / Q000517:prevention & control*; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D006146:Guanidines; D017382:Reactive Oxygen Species; D009569:Nitric Oxide; D011765:Pyruvaldehyde; D019001:Nitric Oxide Synthase; D006152:Cyclic GMP; D005947:Glucose; D000109:Acetylcholine; C004479:pimagedine; D000111:Acetylcysteine
references.citation: Ann N Y Acad Sci. 2008 Apr;1126:231-4
references.pmid: 18079474
references.citation: Pharmacol Rev. 1987 Sep;39(3):163-96
references.pmid: 2827195
references.citation: Mol Cell Biochem. 2007 Dec;306(1-2):133-9
references.pmid: 17660951
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15;877(11-12):1093-100
references.pmid: 19299210
references.citation: Diabetes. 1992 Apr;41(4):552-6
references.pmid: 1376704
references.citation: Curr Med Chem. 2009;16(1):94-112
references.pmid: 19149564
references.citation: Biochem Pharmacol. 1994 Nov 16;48(10):1865-70
references.pmid: 7986197
references.citation: Nature. 1987 Jun 11-17;327(6122):524-6
references.pmid: 3495737
references.citation: Diabetes. 2006 May;55(5):1289-99
references.pmid: 16644685
references.citation: Am Fam Physician. 2009 Aug 1;80(3):265-9
references.pmid: 19621836
references.citation: Circ Res. 1994 Jun;74(6):1141-8
references.pmid: 8187280
references.citation: Cardiovasc Res. 2009 Apr 1;82(1):9-20
references.pmid: 19179352
references.citation: Nature. 1999 Jun 10;399(6736):601-5
references.pmid: 10376603
references.citation: Free Radic Biol Med. 2005 Jan 15;38(2):286-93
references.pmid: 15607912
references.citation: Nature. 2000 Apr 13;404(6779):787-90
references.pmid: 10783895
references.citation: Anal Biochem. 2000 Nov 1;286(1):35-7
references.pmid: 11038270
references.citation: J Hypertens. 1998 Mar;16(3):339-47
references.pmid: 9557927
references.citation: Clin Biochem. 2007 Nov;40(16-17):1232-9
references.pmid: 17825811
references.citation: Artery. 1998;23(1):10-36
references.pmid: 10846614
references.citation: Br J Pharmacol. 2010 Jan;159(1):166-75
references.pmid: 20002105
references.citation: Int J Clin Pract. 2008 Jun;62(6):877-82
references.pmid: 18479281
references.citation: Timely Top Med Cardiovasc Dis. 2008 Feb 04;12:E3
references.pmid: 18392213
references.citation: Am J Hypertens. 2007 Jun;20(6):629-36
references.pmid: 17531919
references.citation: Control Clin Trials. 1999 Oct;20(5):493-510
references.pmid: 10503809
references.citation: Nephrol Dial Transplant. 2004 Jul;19(7):1702-7
references.pmid: 15150351
references.citation: J Clin Invest. 2001 Nov;108(9):1341-8
references.pmid: 11696579
references.citation: J Hypertens. 2008 Apr;26(4):765-72
references.pmid: 18327087
references.citation: Nature. 1988 Jun 16;333(6174):664-6
references.pmid: 3131684
references.citation: Mayo Clin Proc. 2009 Aug;84(8):741-57
references.pmid: 19648392
references.citation: Hypertension. 2002 Mar 1;39(3):809-14
references.pmid: 11897769
references.citation: J Mol Cell Cardiol. 2005 Aug;39(2):327-34
references.pmid: 15978611
references.citation: J Hypertens. 2005 Aug;23(8):1565-73
references.pmid: 16003184
references.citation: Diabetes. 1999 Jan;48(1):1-9
references.pmid: 9892215
references.citation: Biochem J. 1999 Nov 15;344 Pt 1:109-16
references.pmid: 10548540
references.citation: Circ Res. 2001 Jun 8;88(11):E68-75
references.pmid: 11397791
references.citation: Physiol Rev. 2007 Jan;87(1):315-424
references.pmid: 17237348
references.citation: Eur J Pharmacol. 1993 Mar 16;233(1):119-25
references.pmid: 7682510
references.citation: Metabolism. 2008 Sep;57(9):1211-20
references.pmid: 18702946
references.citation: Nature. 1999 Jun 10;399(6736):597-601
references.pmid: 10376602
references.citation: Arch Biochem Biophys. 2009 May 1;485(1):56-62
references.pmid: 19272349
references.citation: Br J Pharmacol. 2000 Jul;130(5):963-74
references.pmid: 10882379
references.citation: Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):89-99
references.pmid: 18221107
references.citation: Lab Invest. 1987 Jul;57(1):94-105
references.pmid: 3298852
references.citation: J Cell Physiol. 1996 May;167(2):213-21
references.pmid: 8613461